Therapy Areas
29 June 2022 - - Japan-based pharmaceutical company Daiichi Sankyo (TSX: 4568) and British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca's (LSE: AZN) (STO: AZN) (NASDAQ: AZN) trastuzumab deruxtecan has been reco...
29 June 2022 - - The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending approval of Lynparza for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm), hum...
29 June 2022 - - The first two patients have been dosed in US-based clinical-stage microbiome company BiomX Inc's (NYSE American: PHGE) Phase 1b/2a study evaluating BX004 for the treatment of chronic respiratory infections in patients with cysti...
29 June 2022 - - The US Food and Drug Administration has approved the Phase 1/2a clinical trial of Singapore-based biopharmaceutical company Prestige Biopharma Ltd's first-in-class anti-PAUF monoclonal antibody, PBP1510 (INN: Ulenistamab), for t...
29 June 2022 - German multinational pharmaceutical and life sciences company Bayer AG (ETR:BAYN) has opened a new Research and Innovation Center in the United States, the company announced on Wednesday.Located at Kendall Square in Boston-Cambridge, M...
29 June 2022 - Chemomab Therapeutics, Ltd. (Nasdaq: CMMB), a clinical stage biotechnology company, announced on Tuesday that the United States Patent and Trademark Office has issued a new patent for CM-101, Chemomab's first-in-class monoclonal a...
29 June 2022 - BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), an Israel-based late clinical-stage biopharmaceutical company, announced on Tuesday that it has signed a collaboration agreement with GenFleet Therapeutics, a China-based immuno-oncology focu...